toyocamycin has been researched along with jasplakinolide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chapuis, JC; Cichacz, Z; Craciunescu, F; Cragg, GM; Doubek, DL; Du, J; Goswami, A; Herald, CL; Hoard, MS; Hogan, F; Hooper, JN; Nogawa, T; Pettit, GR; Pettit, RK; Schmidt, JM; Searcy, J; Tackett, DN; Tackett, L; Tan, R; Williams, L; Xu, JP; Ye, QH | 1 |
| Feng, Y; Hooper, JN; Mellick, G; Murtaza, M; Quinn, RJ; Wang, D; Wood, S | 1 |
2 other study(ies) available for toyocamycin and jasplakinolide
| Article | Year |
|---|---|
Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms(1a,).
Topics: Antineoplastic Agents; Carbazoles; Depsipeptides; Drug Screening Assays, Antitumor; Indole Alkaloids; Marine Biology; Molecular Structure; Oxazoles; Peptides, Cyclic; Piperazines | 2008 |
A Grand Challenge: Unbiased Phenotypic Function of Metabolites from Jaspis splendens against Parkinson's Disease.
Topics: Animals; Depsipeptides; Drug Screening Assays, Antitumor; Humans; Indole Alkaloids; Molecular Structure; Parkinson Disease; Porifera | 2016 |